172 related articles for article (PubMed ID: 36658156)
1. Impact of thyroid cancer on the cancer risk in patients with non-alcoholic fatty liver disease or dyslipidemia.
Ho J; Kim E; Lee M; Jung I; Jo YS; Lee J
Sci Rep; 2023 Jan; 13(1):1076. PubMed ID: 36658156
[TBL] [Abstract][Full Text] [Related]
2. Nonalcoholic Fatty Liver Disease and the Risk of Thyroid Cancer Among Young Adults in South Korea.
Kwon H; Han KD; Moon SJ; Park SE; Rhee EJ; Lee WY
J Clin Endocrinol Metab; 2024 Feb; 109(3):e1095-e1104. PubMed ID: 37921093
[TBL] [Abstract][Full Text] [Related]
3. The risk of incident extrahepatic cancers is higher in non-alcoholic fatty liver disease than obesity - A longitudinal cohort study.
Allen AM; Hicks SB; Mara KC; Larson JJ; Therneau TM
J Hepatol; 2019 Dec; 71(6):1229-1236. PubMed ID: 31470068
[TBL] [Abstract][Full Text] [Related]
4. Associations Between Nonalcoholic Fatty Liver Disease and Cancers in a Large Cohort in China.
Wang Z; Zhao X; Chen S; Wang Y; Cao L; Liao W; Sun Y; Wang X; Zheng Y; Wu S; Wang L
Clin Gastroenterol Hepatol; 2021 Apr; 19(4):788-796.e4. PubMed ID: 32407969
[TBL] [Abstract][Full Text] [Related]
5. Association between non-alcoholic fatty liver disease and the risk of biliary tract cancers: A South Korean nationwide cohort study.
Park JH; Hong JY; Kwon M; Lee J; Han K; Han IW; Kang W; Park JK
Eur J Cancer; 2021 Jun; 150():73-82. PubMed ID: 33892409
[TBL] [Abstract][Full Text] [Related]
6. Effect of Metabolic Traits on the Risk of Cirrhosis and Hepatocellular Cancer in Nonalcoholic Fatty Liver Disease.
Kanwal F; Kramer JR; Li L; Dai J; Natarajan Y; Yu X; Asch SM; El-Serag HB
Hepatology; 2020 Mar; 71(3):808-819. PubMed ID: 31675427
[TBL] [Abstract][Full Text] [Related]
7. Non-alcoholic fatty liver disease is associated with stroke severity and progression of brainstem infarctions.
Li H; Hu B; Wei L; Zhou L; Zhang L; Lin Y; Qin B; Dai Y; Lu Z
Eur J Neurol; 2018 Mar; 25(3):577-e34. PubMed ID: 29281159
[TBL] [Abstract][Full Text] [Related]
8. Significant fibrosis predicts new-onset diabetes mellitus and arterial hypertension in patients with NASH.
Ampuero J; Aller R; Gallego-Durán R; Crespo J; Calleja JL; García-Monzón C; Gómez-Camarero J; Caballería J; Lo Iacono O; Ibañez L; García-Samaniego J; Albillos A; Francés R; Fernández-Rodríguez C; Diago M; Soriano G; Andrade RJ; Latorre R; Jorquera F; Morillas RM; Escudero D; Estévez P; Guerra MH; Augustín S; Banales JM; Aspichueta P; Benlloch S; Rosales JM; Salmerón J; Turnes J; Romero Gómez M;
J Hepatol; 2020 Jul; 73(1):17-25. PubMed ID: 32147361
[TBL] [Abstract][Full Text] [Related]
9. Impact of Dyslipidemia on the Risk of Second Cancer in Thyroid Cancer Patients: A Korean National Cohort Study.
Ho J; Kim E; Han M; Jung I; Lee J; Jo YS
Ann Surg Oncol; 2021 Aug; 28(8):4373-4384. PubMed ID: 33483844
[TBL] [Abstract][Full Text] [Related]
10. Nonalcoholic Fatty Liver Disease and the Development of Metabolic Comorbid Conditions in Patients With Human Immunodeficiency Virus Infection.
Krahn T; Martel M; Sapir-Pichhadze R; Kronfli N; Falutz J; Guaraldi G; Lebouche B; Klein MB; Wong P; Deschenes M; Ghali P; Sebastiani G
J Infect Dis; 2020 Aug; 222(5):787-797. PubMed ID: 32249283
[TBL] [Abstract][Full Text] [Related]
11. Higher free triiodothyronine is associated with non-alcoholic fatty liver disease in euthyroid subjects: the Lifelines Cohort Study.
van den Berg EH; van Tienhoven-Wind LJ; Amini M; Schreuder TC; Faber KN; Blokzijl H; Dullaart RP
Metabolism; 2017 Feb; 67():62-71. PubMed ID: 28081779
[TBL] [Abstract][Full Text] [Related]
12. Non-high-density lipoprotein cholesterol independently predicts new onset of non-alcoholic fatty liver disease.
Zelber-Sagi S; Salomone F; Yeshua H; Lotan R; Webb M; Halpern Z; Santo E; Oren R; Shibolet O
Liver Int; 2014 Jul; 34(6):e128-35. PubMed ID: 24118857
[TBL] [Abstract][Full Text] [Related]
13. Correlation between non-alcoholic fatty liver disease (NAFLD) and dyslipidemia in type 2 diabetes.
Krishan S
Diabetes Metab Syndr; 2016; 10(2 Suppl 1):S77-81. PubMed ID: 26810159
[TBL] [Abstract][Full Text] [Related]
14. Impact of hypothyroidism on the development of non-alcoholic fatty liver disease: A 4-year retrospective cohort study.
Lee KW; Bang KB; Rhee EJ; Kwon HJ; Lee MY; Cho YK
Clin Mol Hepatol; 2015 Dec; 21(4):372-8. PubMed ID: 26770926
[TBL] [Abstract][Full Text] [Related]
15. [Non-alcoholic fatty liver disease (NAFLD)].
Rau M; Weiss J; Geier A
Dtsch Med Wochenschr; 2015 Jul; 140(14):1051-5. PubMed ID: 26182253
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for non-alcoholic fatty liver disease are common in patients with non-B non-C hepatocellular carcinoma in India.
David D; Raghavendran A; Goel A; Bharath Kumar C; Kodiatte TA; Burad D; Abraham P; Ramakrishna B; Joseph P; Ramachandran J; Eapen CE
Indian J Gastroenterol; 2017 Sep; 36(5):373-379. PubMed ID: 28975595
[TBL] [Abstract][Full Text] [Related]
17. Clinical Characteristics and Metabolic Profiles of Non-Alcoholic Fatty Liver Disease (NAFLD) in Lean Patients and Their Comparison with Obese and Overweight NAFLD.
Chakrabarty M; Jha AN; Sharma DJ
J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443531
[TBL] [Abstract][Full Text] [Related]
18. Association between high fatty liver index and development of colorectal cancer: a nationwide cohort study with 21,592,374 Korean.
Choi YJ; Lee DH; Han KD
Korean J Intern Med; 2020 Nov; 35(6):1354-1363. PubMed ID: 32264657
[TBL] [Abstract][Full Text] [Related]
19. Atherogenic dyslipidemia, but not hyperglycemia, is an independent factor associated with liver fibrosis in subjects with type 2 diabetes and NAFLD: a population-based study.
Julián MT; Pera G; Soldevila B; Caballería L; Julve J; Puig-Jové C; Morillas R; Torán P; Expósito C; Puig-Domingo M; Castelblanco E; Franch-Nadal J; Cusi K; Mauricio D; Alonso N
Eur J Endocrinol; 2021 Apr; 184(4):587-596. PubMed ID: 33606661
[TBL] [Abstract][Full Text] [Related]
20. Association between non-alcoholic fatty liver disease and the risk of dementia: A nationwide cohort study.
Kim GA; Oh CH; Kim JW; Jeong SJ; Oh IH; Lee JS; Park KC; Shim JJ
Liver Int; 2022 May; 42(5):1027-1036. PubMed ID: 35289469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
